For: | Cassese G, Han HS, Lee B, Lee HW, Cho JY, Panaro F, Troisi RI. Immunotherapy for hepatocellular carcinoma: A promising therapeutic option for advanced disease. World J Hepatol 2022; 14(10): 1862-1874 [PMID: 36340753 DOI: 10.4254/wjh.v14.i10.1862] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v14/i10/1862.htm |
Number | Citing Articles |
1 |
Yanbing Dong, Ying Huang, Zhe Zhang, Aoxing Chen, Lin Li, Manman Tian, Jie Shen, Jie Shao. iRGD-modified memory-like NK cells exhibit potent responses to hepatocellular carcinoma. Journal of Translational Medicine 2023; 21(1) doi: 10.1186/s12967-023-04024-7
|
2 |
Gianluca Cassese, Ho-Seong Han, Yoo-Seok Yoon, Jun Suh Lee, Boram Lee, Antonio Cubisino, Fabrizio Panaro, Roberto Ivan Troisi. Role of neoadjuvant therapy for nonmetastatic pancreatic cancer: Current evidence and future perspectives. World Journal of Gastrointestinal Oncology 2023; 15(6): 911-924 doi: 10.4251/wjgo.v15.i6.911
Abstract(341) |
Core Tip(303) |
Full Article(HTML)(1757)
|
Full Article with Cover (PDF)-797K(78)
|
Full Article (Word)-180K(35)
|
Audio-186K(2)
|
Peer-Review Report-307K(41)
|
Answering Reviewers-39K(42)
|
Full Article (PDF)-493K(150)
|
Full Article (XML)-311K(44)
|
Times Cited (7)
|
Total Visits (3864)
|
Open
|
3 |
Gianluca Cassese, Ho-Seong Han, Jai Young Cho, Hae-Won Lee, Boram Lee, Roberto Ivan Troisi. Selecting the Best Approach for the Treatment of Multiple Non-Metastatic Hepatocellular Carcinoma. Cancers 2022; 14(23): 5997 doi: 10.3390/cancers14235997
|
4 |
Hongliang Ou, Yunsong Qian, Li Ma. MCF2L-AS1 promotes the biological behaviors of hepatocellular carcinoma cells by regulating the miR-33a-5p/FGF2 axis. Aging 2023; 15(13): 6100 doi: 10.18632/aging.204795
|
5 |
Yu-Xue Gao, Qi-Qi Ning, Peng-Xiang Yang, Yuan-Yue Guan, Peng-Xiang Liu, Meng-Lu Liu, Lu-Xin Qiao, Xiang-Hua Guo, Tong-Wang Yang, De-Xi Chen. Recent advances in recurrent hepatocellular carcinoma therapy. World Journal of Hepatology 2023; 15(4): 460-476 doi: 10.4254/wjh.v15.i4.460
|
6 |
Shijing Tang, Hao Chen.
Prognostic Significance of Iron Metabolism and Immune-Related Genes as Risk Markers in Hepatocellular Carcinoma
. Journal of Environmental Pathology, Toxicology and Oncology 2024; 43(3): 51 doi: 10.1615/JEnvironPatholToxicolOncol.2024050167
|